Aetna Inc. now has permission from the Centers for Medicare and Medicaid Services (CMS) to resume selling Medicare plans.
CMS suspended the ability of Aetna, Hartford (NYSE:AET), to sell new Medicare Advantage and Medicare Part D prescription drug coverage in April 2010 because of concerns about Aetna's switch to a closed Medicare Part D "formulary," or covered drugs list, from an open formulary.
Aetna will resume marketing Medicare Advantage and drug plan products immediately, the company says. The company can enroll beneficiaries with effective dates beginning July 1.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Allison Bell
Allison Bell, a senior reporter at ThinkAdvisor and BenefitsPRO, previously was an associate editor at National Underwriter Life & Health. She has a bachelor's degree in economics from Washington University in St. Louis and a master's degree in journalism from the Medill School of Journalism at Northwestern University. She can be reached through X at @Think_Allison.
